Anant Madabhushi, PhD, is the Donnell Institute Professor of biomedical
engineering at Case Western Reserve University (CWRU) in Cleveland and
director of the university’s Center for Computational Imaging and Personalized
Diagnostics (CCIPD). He is also a Research Scientist at the Louis Stokes
Cleveland Veterans Administration (VA) Medical Center and has affiliate
appointments both at University Hospitals and Cleveland Clinic. He holds
secondary appointments in the departments of Biomedical Engineering, Urology,
Radiology, Pathology, Radiation Oncology, Electrical Engineering & Computer
Science and Gen Med Sciences at CWRU.
Madabhushi’s team at CCIPD is developing and applying novel Artificial
Intelligence and machine learning approaches for the diagnosis, prognosis
and prediction of therapy response for a variety of diseases including several
different types of cancers, cardiovascular disease, kidney and eye disease.
The Center is located in Cleveland’s unique medical ecosystem, an extensive
clinical network within which it boasts numerous successful collaborations
including with the Cleveland Clinic and the Cole Eye Institute, University
Hospitals, the VA Louis Stokes Medical Center, MetroHealth, and the Case
Comprehensive Cancer Center at CWRU.
Madabhushi has more than 100 patents either issued or pending in the areas of
medical image analysis, computer-aided diagnosis, and computer vision, more than
60 of which are issued. He was responsible for more than 10 percent of all patents
awarded to Case Western Reserve University in 2017, 2018 and 2019.
The author of more than 400 peer-reviewed journal articles and conference papers,
Madabhushi is a sought after lecturer who has delivered more than 345 talks
around the world. His efforts as a professor and researcher have gained
international attention in the field of biomedical engineering, garnering
him several awards. Most notably, Madabhushi is a fellow of the American
Institute of Medical and Biomedical Engineering (AIMBE), a Fellow of the
Institute of Electrical and Electronics Engineers (IEEE) and a fellow of
the National Academy of Inventors (NAI). In 2015, he made Crain’s Cleveland
Business magazine’s “Forty under 40” list. In 2019 and 2020, Madabhushi was
named to The Pathologist's Power List, a list of 100 most inspiring professionals
in pathology and laboratory medicine. In 2020, he received the Diekhoff Award
for Distinguished Graduate Student Mentoring at CWRU.
Madabhushi’s work on developing “smart computers for identifying lung
cancer patients who will benefit from chemotherapy” was ranked as one of
the top 10 medical breakthroughs of 2018 by Prevention Magazine. In 2019,
Nature Magazine called him out as one of five scientists pursuing truly offbeat
and innovative approaches in cancer research. His work on using AI for addressing
health disparities, especially in identifying differences in appearance of
prostate cancer between black and white men, received national attention in 2020.
Madabhushi has secured more than $60 million in grant funding and co-founded two
companies, Vascuvis Inc. (now Elucid Bioimaging) and IbRiS Inc., which was acquired
by Inspirata in 2015. He has been involved in several sponsored research and
industry partnerships with medical imaging and pharmaceutical companies.
In addition, more than 15 technologies developed by Madabhushi’s team have been licensed.